Africa Nuclear Imaging Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Africa Nuclear Imaging Market is segmented by Product (Equipment and Radioisotope), Application (SPECT Applications and PET Applications). The report offers the value (in USD million) for the above segments.

Market Snapshot

None
Study Period: 2019-2027
Base Year: 2021
CAGR: 9.8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Africa nuclear imaging market is expected to grow with a CAGR of 9.8% during the forecast period.

COVID-19 has had a huge impact on patients and healthcare providers as they became self-selective about nuclear imaging procedures, which were categorized as non-essential. The pandemic affected the operations of hospitals and doctors too, as healthcare professionals prioritized COVID-19 procedures and postponed many elective surgeries and radiation treatments, due to which there was a decrease in the demand for related PET scans. As per the study published in June 2022 titled "Impact of COVID-19 on Nuclear Medicine Departments in Africa and Latin America", among the nuclear medicine procedures, oncological PET studies showed less of a decline in utilization compared to conventional nuclear medicine studies. A gradual trend toward a return to the pre-COVID-19 status of the supply chains of radioisotopes, generators, and other essential materials was evident. Overall, in 2020, the pandemic-related challenges resulted in a significant decrease in nuclear medicine diagnostic and therapeutic procedures in Africa and Latin America. Thus, COVID-19 impacted the nuclear imaging market as there were distribution channel disruptions for most radiopharmaceuticals, delays in clinical studies, postponement of various surgeries and imaging procedures, an increase in teleradiology, and several staff-related limitations.

Certain factors that are propelling the growth of the market include technological advancements; increasing diagnostic applications in various diseases, such as cancer and cardiovascular diseases; government support; and a shift from standalone to hybrid modalities. The technological advancements in the field of imaging have always been challenging to practitioners in order to optimize them in patient care. Over recent years, scientists, researchers, and technologists have been able to bring systems into clinical practice in which two or even more than two standalone diagnostic imaging modalities are combined.

In February 2022, the International Atomic Energy Agency (IAEA) launched a plan to tackle a severe shortage of cancer care capacity in many countries, with an initial focus on Africa, where people often die from the disease due to the lack of access to potentially life-saving nuclear medicine and radiotherapy. Moreover, in July 2020, the United States National Nuclear Security Administration awarded grants totaling USD 1.5 million to support an increase in medical staff and the building of facilities and equipment in sub-Saharan Africa.

Owing to the factors mentioned above, Africa nuclear imaging market is anticipated to witness growth over the forecast period. However, regulatory issues and a lack of reimbursement may restrain the market's growth.

Scope of the report

As per the scope of the report, nuclear medicine imaging procedures are non-invasive, with the exception of intravenous injections, and are usually painless medical tests that help physicians diagnose and evaluate medical conditions. These imaging scans use radioactive materials called radiopharmaceuticals or radiotracers. These radiopharmaceuticals are used in diagnosis and therapeutics. They are small substances that contain a radioactive substance that is used in the treatment of cancer, and cardiac and neurological disorders. The Africa Nuclear Imaging Market is segmented by Product (Equipment and Radioisotope), Application (SPECT Applications and PET Applications). The report offers the value (in USD million) for the above segments.

By Product
By Equipment
By Radioisotope
SPECT Radioisotopes
Technetium-99m (TC-99m)
Thallium-201 (TI-201)
Gallium (Ga-67)
Iodine (I-123)
Other SPECT Radioisotopes
PET Radioisotopes
Fluorine-18 (F-18)
Rubidium-82 (RB-82)
Other PET Radioisotopes
By Application
SPECT Applications
Cardiology
Neurology
Thyroid
Other SPECT Applications
PET Applications
Oncology
Cardiology
Neurology
Other PET Applications
Rest of Europe

Report scope can be customized per your requirements. Click here.

Key Market Trends

Oncology Segment is Expected to Hold the Highest Market Share in PET Applications Over the Forecast Period

The major factors responsible for the growth of this segment include the rise in the prevalence of cancers that require advanced diagnostics like PET/CT scans. For instance, as per the GLOBOCAN data updated in 2020, the number of new cancer cases in 2020 was 1.11 million and it is expected to rise to a count of 2.10 million by 2040. This high incidence of cancer is expected to increase the demand for nuclear imaging for its early diagnosis, which is further expected to fuel the market segment growth in the coming years.

The fluorodeoxyglucose (FDG)-positron emission tomography (PET)/CT is more sensitive than a contrast-enhanced CT scan in the staging of several types of lymphoma or in detecting tumor dissemination in several solid cancers, such as breast cancer, lung cancer, and colon cancer.

As per an article published in February 2022 by the International Atomic Energy Agency titled "Building Radiopharmaceutical Sustainability for Cancer Care in Africa", the IAEA is helping African countries to build expertise through education and training programs, and to develop their facilities to locally produce radiopharmaceuticals, which in many cases have a short shelf life and need to be used quickly after production. Thus, owing to such instances, the segment is expected to witness growth over the forecast period.

Hence, due to the factors mentioned above, the oncology segment of the market is expected to witness growth over the forecast period.

None

Competitive Landscape

The Africa nuclear imaging market is highly competitive and consists of a few major players. In terms of market share, a few of the major players currently dominate the market. Companies like Bracco Imaging SpA, Curium, Cardinal Health Inc., Koninklijke Philips NV, General Electric Company (GE Healthcare), and Siemens Healthineers, among others, hold a substantial share in the market.

Major Players

  1. Bracco Imaging SpA

  2. Cardinal Health Inc.

  3. Koninklijke Philips NV

  4. Siemens Healthineers

  5. General Electric Company (GE Healthcare)

PictureF.png

Recent Developments

  • In May 2022, the MANDELA project officially launched at UWC and UniZulu, in collaboration with the University of York, to open nuclear physics laboratories in South Africa.
  • In February 2022, the International Atomic Energy Agency (IAEA) launched a plan to tackle a severe shortage of cancer care capacity in many poorer countries, with an initial focus on Africa where people often die from the disease because they lack access to potentially life-saving nuclear medicine and radiotherapy.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Prevalence of Cancer and Cardiac Disorders

      2. 4.2.2 Increase in Technological Advancements

      3. 4.2.3 Growth in Applications of Nuclear Medicine and Imaging

    3. 4.3 Market Restraints

      1. 4.3.1 Regulatory Issues

      2. 4.3.2 Lack of Reimbursement

    4. 4.4 Portere's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Product

      1. 5.1.1 By Equipment

      2. 5.1.2 By Radioisotope

        1. 5.1.2.1 SPECT Radioisotopes

          1. 5.1.2.1.1 Technetium-99m (TC-99m)

          2. 5.1.2.1.2 Thallium-201 (TI-201)

          3. 5.1.2.1.3 Gallium (Ga-67)

          4. 5.1.2.1.4 Iodine (I-123)

          5. 5.1.2.1.5 Other SPECT Radioisotopes

        2. 5.1.2.2 PET Radioisotopes

          1. 5.1.2.2.1 Fluorine-18 (F-18)

          2. 5.1.2.2.2 Rubidium-82 (RB-82)

          3. 5.1.2.2.3 Other PET Radioisotopes

    2. 5.2 By Application

      1. 5.2.1 SPECT Applications

        1. 5.2.1.1 Cardiology

        2. 5.2.1.2 Neurology

        3. 5.2.1.3 Thyroid

        4. 5.2.1.4 Other SPECT Applications

      2. 5.2.2 PET Applications

        1. 5.2.2.1 Oncology

        2. 5.2.2.2 Cardiology

        3. 5.2.2.3 Neurology

        4. 5.2.2.4 Other PET Applications

        5. 5.2.2.5 Rest of Europe

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bracco Imaging SpA

      2. 6.1.2 Cardinal Health Inc.

      3. 6.1.3 General Electric Company (GE Healthcare)

      4. 6.1.4 Koninklijke Philips NV

      5. 6.1.5 Siemens Healthineers

      6. 6.1.6 Curium

      7. 6.1.7 CMR NAVISCAN (GAMMA MEDICA INC.)

      8. 6.1.8 Nordion (Canada) Inc.

      9. 6.1.9 NTP Radioisotopes SOC

      10. 6.1.10 Canon Medical Systems Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Africa Nuclear Imaging Market market is studied from 2019 - 2027.

The Africa Nuclear Imaging Market is growing at a CAGR of 9.8% over the next 5 years.

Bracco Imaging SpA , Cardinal Health Inc., Koninklijke Philips NV , Siemens Healthineers, General Electric Company (GE Healthcare) are the major companies operating in Africa Nuclear Imaging Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!